The nuclear medicine group of Siemens Medical Systems received Food and Drug Administration clearance last month for a version of its E.Cam gamma camera that uses hybrid PET/SPECT detectors made from lutetium oxyortho-silicate and sodium iodide
The nuclear medicine group of Siemens Medical Systems received Food and Drug Administration clearance last month for a version of its E.Cam gamma camera that uses hybrid PET/SPECT detectors made from lutetium oxyortho-silicate and sodium iodide (LSO/NaI). The Hoffman Estates, IL, division developed the hybrid system in collaboration with R&D partner CTI of Nashville. It featured the unit at last months Society of Nuclear Medicine conference in Toronto (SCAN Special Report June 1998). Siemens hopes the hybrid detectors will enable nuclear medicine physicians to image radioisotopes at both low and high energy ranges, making the camera equally suitable for either SPECT or PET studies.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.